An open-label trial of gabapentin treatment of paroxysmal symptoms in multiple sclerosis patients

Neurology

Volumn 51, Issue 2, 1998, Pages 609-611

  Solaro, C ^b   Lunardi, G L ^c   Capello, E ^c   Inglese, M ^a   Messmer Uccelli, M ^c   Uccelli, A ^c   Mancardi, G L ^c  

^a Italian Multiple Sclerosis Society   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

GABAPENTIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; DYSESTHESIA; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; MUSCLE SPASM; NAUSEA; PARESTHESIA; PRIORITY JOURNAL; TREATMENT OUTCOME; TRIGEMINUS NEURALGIA; VERTIGO;

EID: 0031723846     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.51.2.609     Document Type: Article

References (10)

1. Schapiro RT, Baumhefner RW, Tourtellotte WW. Multiple sclerosis: a clinical viewpoint to management. In: Raine CS, McFarland HF, Tourtellotte WW, eds. Multiple sclerosis: clinical and pathogenetic basis. London: Chapman & Hall, 1997: 391-420.
2. Chadwick D. Gabapentin. Lancet 1994;343:89-91.
3. Sist T, Filadora V, Miner M, Lema M. Gabapentin for idiopathic trigeminal neuralgia: report of two cases. Neurology 1997;48:1467.
4. Averbuch-Heller L, Tusa RJ, Fuhry L, et al. A double-blind controlled study of gabapentin and baclofen as treatment for acquired nystagmus. Ann Neurol 1997;41:818-825.
5. Mueller ME, Gruenthal M, Olson WL, Olson WH. Gabapentin for relief of upper motor neuron symptoms in multiple sclerosis. Arch Phys Med Rehabil 1997;78:521-524.
6. Samkoff LM, Daras M, Tuchman AJ, Koppel BS. Amelioration of refractory dysesthetic limb pain in multiple sclerosis by gabapentin. Neurology 1997;49:304-305.
7. Lunardi G, Leandri M, Albano C , et al. Lamotrigine clinical effectiveness and plasma levels in idiopathic and symptomatic trigeminal neuralgia. Neurology 1997;49:1714-1717.
8. The US Gabapentin Study Group No. 5 Gabapentin as add-on therapy in refractory partial epilepsy: A double-blind, placebo-controlled, parallel-group study. Neurology 1993;43:2292-2297.
9. McLean MJ. Clinical pharmacokinetics of gabapentin. Neurology 1994;44(suppl 5):S17-S22.
10. Taylor CP. Emerging perspectives on the mechanism of action of gabapentin. Neurology 1994;44(suppl 5):S10-S16.